Market research

Endoscope Cleaning & Disinfection Equipment Market

Explore licenses

Assess the study’s coverageRead the public overview, then compare the chapter outline with your research brief.

16report chapters

360iResearch introduction

Public research overview

Endoscope Cleaning and Disinfection Equipment: Executive Overview

Endoscope cleaning and disinfection equipment supports the safe reprocessing of reusable flexible and rigid endoscopes between procedures. The market is shaped by infection-prevention requirements, device complexity, workflow capacity, water quality, staff competency, traceability, and the need to reduce variability in manual cleaning. Verified guidance from public-health and professional bodies consistently emphasizes point-of-use treatment, validated cleaning, appropriate high-level disinfection or sterilization, drying, storage, and documentation. Demand is therefore linked less to equipment alone than to complete, auditable reprocessing systems.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to see every subchapter in context.

  1. Chapter 7 Product Type

    • Automated Endoscope Reprocessors (AERs)
    • Washer-Disinfectors
    • Ultrasonic Cleaners
    • Drying and Storage Cabinets
    More in this chapter
  2. Chapter 8 Endoscope Type

    • Flexible Endoscopes
    • Rigid Endoscopes
    • Semi-rigid Endoscopes
    View chapter
  3. Chapter 9 Modality

    • Standalone/Benchtop
    • Portable
    View chapter

Why Reprocessing Standards and Workflow Design Are Reshaping the Landscape

The landscape is shifting from isolated equipment purchases toward integrated reprocessing pathways. Automated endoscope reprocessors, drying and storage cabinets, leak testers, cleaning accessories, water-treatment systems, and digital tracking tools are increasingly assessed as parts of a controlled workflow. Regulatory scrutiny and published infection investigations have reinforced the importance of manufacturer instructions, compatibility validation, routine maintenance, staff training, and separation of dirty and clean activities. Hospitals and ambulatory facilities are also prioritizing ergonomic design, throughput, environmental controls, and documented quality assurance when upgrading reprocessing areas.

Artificial Intelligence Is Strengthening Traceability and Quality Control

Artificial intelligence is most relevant as an augmentation layer rather than a replacement for validated reprocessing procedures. Potential applications include detecting anomalies in cycle records, identifying incomplete documentation, supporting predictive maintenance, organizing inventory, and flagging workflow deviations for human review. Computer vision may eventually assist with inspection of surfaces and accessories, but cleaning efficacy still requires validated processes and appropriate testing. Leaders should require explainability, cybersecurity, data governance, human oversight, and clinical validation before using AI-generated alerts in infection-prevention decisions.

Regional Insights: Regulation, Infrastructure, and Access Create Distinct Priorities

North America generally emphasizes detailed reprocessing guidance, documentation, staff competency, and device traceability, while facilities continue to address capacity and design constraints. Europe places strong weight on harmonized standards, risk management, water quality, and validated workflow separation, although implementation differs across health systems. Asia-Pacific combines advanced hospital infrastructure in markets such as Japan, Australia, and South Korea with rapid capacity expansion and uneven access elsewhere. Latin America is balancing infection-prevention improvement with budget, training, service, and infrastructure constraints. The Middle East is investing in modern hospital facilities and centralized workflows, with regulatory alignment and skilled staffing remaining important. Africa presents highly varied conditions, making resilient equipment, local technical support, water reliability, and practical training especially significant.

Group Insights: Common Standards Meet Uneven Implementation Capacity

ASEAN members face differing regulatory maturity, healthcare access, and technical-service conditions, so scalable systems and competency-based training are central priorities. BRICS economies combine substantial hospital demand with varied procurement models, domestic manufacturing capabilities, and uneven reprocessing infrastructure. The European Union benefits from shared regulatory principles and standards, while national purchasing and facility practices still differ. G7 health systems tend to prioritize traceability, validation, sustainability, and workforce assurance. GCC countries are developing high-capacity healthcare infrastructure and often emphasize centralized, standardized reprocessing. NATO members do not form a single healthcare procurement system, but shared attention to resilience, continuity, and interoperable digital practices can influence institutional priorities.

Country Insights: National Health-System Conditions Shape Adoption

Australia and Canada emphasize national infection-prevention guidance, rural access, competency, and traceability. The United States places strong attention on manufacturer instructions, regulatory compliance, documentation, and facility-level quality assurance. Brazil and Mexico are addressing uneven infrastructure and the need for standardized training across public and private settings. China is expanding modern hospital capacity while strengthening domestic standards, service networks, and process control. India’s priorities include affordability, scalable workflows, water and utility reliability, and staff training. Japan and South Korea emphasize precision, automation, quality systems, and advanced hospital operations. France, Germany, Italy, Spain, and the United Kingdom operate within mature regulatory environments where standards, procurement rules, sustainability, and workforce capacity influence equipment selection. Russia’s requirements are shaped by national regulation, healthcare infrastructure, and service availability.

Actions for Leaders: Build Validated, Traceable, and Resilient Reprocessing Systems

Leaders should map the entire dirty-to-clean workflow before selecting equipment, then verify compatibility with each endoscope model, detergent, disinfectant, accessory, and storage method. Establish measurable controls for point-of-use treatment, manual cleaning, automated cycles, drying, storage, water quality, maintenance, and release decisions. Use electronic traceability to link patients, devices, operators, cycles, maintenance, and exceptions, with privacy and cybersecurity safeguards. Invest in recurring competency assessment rather than one-time instruction, and maintain contingency plans for equipment downtime, utility interruptions, supply shortages, and unexpected contamination events. Procurement teams should evaluate lifecycle support, validation evidence, service response, consumable dependence, energy and water use, and interoperability alongside acquisition cost.

Research Methodology: Evidence-Led Review of Reprocessing Requirements

This executive summary is based on a qualitative synthesis of authoritative infection-prevention guidance, regulatory expectations, professional standards, public-health publications, and documented healthcare reprocessing practices. The analysis compares equipment functions and operating requirements across regions, country contexts, and the specified economic and geopolitical groups. It focuses on validated cleaning and disinfection principles, workflow design, traceability, training, infrastructure, sustainability, and emerging digital capabilities. No market estimates, market shares, forecasts, or company-specific claims are used. Findings should be interpreted alongside current national regulations, device manufacturer instructions, facility risk assessments, and local water and utility conditions.

Conclusion: Reliable Outcomes Depend on the Entire Reprocessing Ecosystem

The direction of endoscope cleaning and disinfection equipment is being defined by safety, standardization, traceability, and operational resilience. Equipment can reduce variability and strengthen control, but it cannot compensate for unsuitable workflow design, inadequate manual cleaning, poor drying, insufficient training, or missing documentation. Organizations that combine validated technology with competent staff, effective governance, lifecycle service, and continuous auditing will be better positioned to manage infection-prevention obligations across diverse care settings. The most durable strategy is an integrated reprocessing system designed around patient safety and verifiable performance.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Endoscope Cleaning & Disinfection Equipment Market, by Product Type
    1. 7.1Introduction
    2. 7.2Automated Endoscope Reprocessors (AERs)
    3. 7.3Washer-Disinfectors
    4. 7.4Ultrasonic Cleaners
    5. 7.5Drying and Storage Cabinets
    6. 7.6Flushing Pumps
  8. 8.Endoscope Cleaning & Disinfection Equipment Market, by Endoscope Type
    1. 8.1Introduction
    2. 8.2Flexible Endoscopes
    3. 8.3Rigid Endoscopes
    4. 8.4Semi-rigid Endoscopes
  9. 9.Endoscope Cleaning & Disinfection Equipment Market, by Modality
    1. 9.1Introduction
    2. 9.2Standalone/Benchtop
    3. 9.3Portable
  10. 10.Endoscope Cleaning & Disinfection Equipment Market, by End User
    1. 10.1Introduction
    2. 10.2Hospitals
    3. 10.3Ambulatory Surgical Centers (ASCs)
    4. 10.4Specialty Clinics
  11. 11.Endoscope Cleaning & Disinfection Equipment Market, by Region
    1. 11.1Introduction
    2. 11.2Asia-Pacific
    3. 11.3North America
    4. 11.4Latin America
    5. 11.5Europe
    6. 11.6Middle East
    7. 11.7Africa
  12. 12.Endoscope Cleaning & Disinfection Equipment Market, by Group
    1. 12.1Introduction
    2. 12.2ASEAN
    3. 12.3GCC
    4. 12.4European Union
    5. 12.5BRICS
    6. 12.6G7
    7. 12.7NATO
  13. 13.Endoscope Cleaning & Disinfection Equipment Market, by Country
    1. 13.1Introduction
    2. 13.2United States
    3. 13.3Canada
    4. 13.4Mexico
    5. 13.5Brazil
    6. 13.6United Kingdom
    7. 13.7Germany
    8. 13.8France
    9. 13.9Russia
    10. 13.10Italy
    11. 13.11Spain
    12. 13.12China
    13. 13.13India
    14. 13.14Japan
    15. 13.15Australia
    16. 13.16South Korea
  14. 14.Competitive Landscape
    1. 14.1Market Share Analysis, 2025
    2. 14.2Market Concentration Analysis, 2025
      1. 14.2.1Concentration Ratio (CR)
      2. 14.2.2Herfindahl Hirschman Index (HHI)
    3. 14.3Recent Developments & Impact Analysis, 2025
    4. 14.4Product Portfolio Analysis, 2025
    5. 14.5Benchmarking Analysis, 2025
  15. 15.Company Profiles
    1. 15.1Advanced Sterilization Products, Inc.
    2. 15.2BHT Hygiene Technology GmbH
    3. 15.3Choyang Medical Industry Co., Ltd.
    4. 15.4Custom Ultrasonics, Inc.
    5. 15.5Getinge AB
    6. 15.6Medivators Inc.
    7. 15.7Olympus Corporation
    8. 15.8SciCan Ltd.
    9. 15.9Soluscope S.A.
    10. 15.10Steelco S.p.A.
    11. 15.11STERIS plc
    12. 15.12Wassenburg Medical B.V.
  16. 16.Key Experts

Loading the sample request form…